Clinical trial · Interventional
Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma
Study of Efficacy of Oncology Dashboard in Improving Operational Efficiency and Patient Outcomes
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial investigates whether measuring and presenting information about a patient's cancer treatment to them, their doctor, and their radiologist using a tool called an "oncology dashboard" may help patients understand the disease better and help the patient's medical team manage their care more efficiently. The oncology dashboard tool may help patients understand the disease better and may help improve the efficiency of their medical care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Best Practice | Other | — | UNRESOLVED |
| Informational Intervention | Other | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group I (oncology dashboard)
- description
- Radiologist records information from patient's recent scan into oncology dashboard. Patients view images of how disease may have changed over time on oncology dashboard.
- interventionNames
- Other: Informational Intervention
- Other: Questionnaire Administration
- type
- EXPERIMENTAL
- label
- Group II (standard of care)
- description
- Patients receive standard of care.
- interventionNames
- Other: Best Practice
- Other: Questionnaire Administration
Primary outcomes (1)
- measure
- Time to complete medical oncology review (oncology workflow)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with sarcoma on active chemotherapy/targeted therapy * Patients must have stable to mildly progressive disease or better on baseline assessment * Baseline measurement and follow-up measurement have to be performed on the same treatment for consistency. If patients with progressive disease are included into the study at baseline, follow-up measurement will be on a different treatment. Invariable, initiation of a new treatment, in the setting of progressive disease, lengthens oncology workflow which would affect the post measurement * Patients must have been on the same treatment for at least 6 weeks * Patients must have at least 3 prior imaging studies of the same body part/tracked lesion/area of interest separated by 6 weeks or more between studies * Patients should be continuing same therapy for the next 6-8 weeks * Patients must have plan for follow-up with imaging studies at MD Anderson Cancer Center (MDACC) while on therapy * Patients who are receiving therapy outside of MDACC but having their follow-up imaging at MDACC are eligible * \>= 18 years of age Exclusion Criteria: * Expected survival of less than 8 weeks * Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 4 * Non- English-speaking patients and patients with cognitive impairment who cannot complete the questionnaire
References
Publications (0)
Data not yet available